| Financial Year |
March 31 2023 |
| Monetary Funds |
3,661,694,146.12 |
| Held-for-trading Financial Assets |
209,020,043.60 |
| Notes Receivable |
630,377,582.54 |
| Accounts Receivable |
334,418,479.83 |
| Advances to Suppliers |
1,108,042,296.65 |
| Other Receivables |
27,216,869.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,672,767,633.48 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
75,100,220.49 |
| Other Current Assets |
355,062,933.12 |
| Total Current Assets |
9,975,723,879.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
25,029,702.32 |
| Long-term Equity Investment |
3,499,972.63 |
| Investment Properties |
-- |
| Fixed Assetes |
9,918,586,298.22 |
| Under-construction Projects |
2,905,501,870.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
623,099,625.30 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
20,404,263.64 |
| Deferred Income Tax Assets |
396,591,905.62 |
| Other Non-Current Assets |
659,450,079.91 |
| Sub-Total of Non-Current Assets |
15,425,232,676.19 |
| Total Assets |
25,400,956,555.48 |
| Short-Term Loans |
490,658,361.07 |
| Trading Financial liabilities |
9,109,815.76 |
| Notes Payable |
5,517,827,214.30 |
| Accounts Payable |
1,532,166,922.35 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
331,730,674.78 |
| Taxes Payable |
133,961,069.25 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
62,600,891.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,265,934,604.30 |
| Other Current Liabilities |
214,195,093.59 |
| Sub-Total of Current Liabilities |
10,587,059,935.79 |
| Long-term Loans |
2,338,491,784.39 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
457,253,450.41 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
404,887,046.95 |
| Other Non-Current Liabilities |
23,550,000.00 |
| Sub-Total of Non-Current Liabilities |
5,047,551,460.34 |
| Total Liabilities |
15,634,611,396.13 |
| Paid-In Capital(Or Share Stock) |
1,302,650,333.00 |
| Capital Surplus |
4,012,486,751.93 |
| Surplus Reserve |
123,691,566.10 |
| LESS:Treasury Stock |
27,803,393.90 |
| Undistributed Profits |
4,355,123,963.06 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,766,345,159.35 |
| Owner's Equity（Stockholder's Equity） |
9,766,345,159.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
25,400,956,555.48 |
